J&J Says No To Reviving Stelara Case
Johnson & Johnson has asked the Fourth Circuit not to revive CareFirst's antitrust suit alleging the company tried to monopolize the market for the immunosuppressive drug Stelara....To view the full article, register now.
Already a subscriber? Click here to view full article